Human Patient-Derived Colorectal Cancer Organoid – Lower Sigmoid is a 3D tumor model derived from a colorectal cancer patient’s lower sigmoid colon tissue. This organoid retains the structural and genetic characteristics of the original tumor, including regional specificity and cellular heterogeneity. It maintains long-term growth in vitro and accurately reproduces the microenvironment and molecular profile of sigmoid colon tumors. The model provides a stable and reproducible platform for studying colorectal tumor biology, especially site-specific disease progression and treatment response.
Embedded 3D Culture
All test negative for mycoplasma, bacteria, yeast, and fungi.
For research use only. Human Patient-Derived Colorectal Cancer Organoid – Lower Sigmoid is suitable for evaluating drug efficacy and resistance mechanisms in sigmoid colon cancers. It is valuable for understanding region-specific tumor behavior, identifying predictive biomarkers, and testing targeted therapies. Its consistent growth and preserved tumor features make it a powerful tool for translational research, particularly in the development of personalized treatment strategies and preclinical screening of therapeutic agents.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.
Whether you're exploring disease mechanisms or screening novel therapeutics, OgCelix is your trusted partner.
Let's build the future of translational research together.